PHRX (Pharmagen) OCF Margin %: 3.64% (As of Mar. 2014)

What is Pharmagen OCF Margin %?

Pharmagen PHRX -90.00% OCF Margin % is 3.64% as of Mar. 2014.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Pharmagen's Cash Flow from Operations for the three months ended in Mar. 2014 was $0.05 Mil. Pharmagen's Revenue for the three months ended in Mar. 2014 was $1.32 Mil. Therefore, Pharmagen's OCF Margin % for the quarter that ended in Mar. 2014 was 3.64%.

As of today, Pharmagen's current OCF Yield % is -147,800.00%.

The historical rank and industry rank for Pharmagen's OCF Margin % or its related term are showing as below:

PHRX' s OCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -10.97

PHRX's OCF Margin % is not ranked
in the Medical Distribution industry.
Industry Median: 2.24 vs PHRX: -10.97

Pharmagen OCF Margin % Related Terms

Pharmagen OCF Margin % Historical Data

* Premium members only.

The historical data trend for Pharmagen's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmagen OCF Margin % Chart

Pharmagen Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

OCF Margin %

0.00

-51.21

-14.38

Pharmagen Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14
OCF Margin %	Get a 7-Day Free Trial													-9.36	-38.56	-11.55	-3.07	3.64

PHRX vs FZMD, SNYR, SGMFF: OCF Margin % Comparison

For the Medical Distribution subindustry, Pharmagen's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmagen OCF Margin % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmagen's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Pharmagen's OCF Margin % falls into.

Save Embed

Pharmagen OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Pharmagen's OCF Margin for the fiscal year that ended in Dec. 2013 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2013 )	/	Revenue (A: Dec. 2013 )
	=	-0.692	/	4.813
	=	-14.38 %

Pharmagen's OCF Margin for the quarter that ended in Mar. 2014 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2014 )	/	Revenue (Q: Mar. 2014 )
	=	0.048	/	1.319
	=	3.64 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of 3.64% mean?

Pharmagen (PHRX) has a OCF Margin % of 3.64% as of Mar. 2014. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharmagen and its competitors.

Is Pharmagen's OCF Margin % too high?

Pharmagen's current OCF Margin % is 3.64%. The Medical Distribution industry median OCF Margin % is 2.24. Pharmagen's value of 3.64% is 62.5% above this industry median.

How does Pharmagen's OCF Margin % compare to FZMD and SNYR?

Pharmagen's OCF Margin % of 3.64% can be compared against companies in the Medical Distribution industry. The industry median OCF Margin % is 2.24. Pharmagen's value of 3.64% is 62.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Medical Distribution company?

The median OCF Margin % among Medical Distribution companies is 2.24, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmagen's current OCF Margin % of 3.64% is 62.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pharmagen and its competitors. For the Medical Distribution industry, the median OCF Margin % is 2.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmagen's current OCF Margin % is 3.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pharmagen stock overvalued right now?

Pharmagen (PHRX) has a current OCF Margin % of 3.64%. The current OCF Margin % is 3.64% and 62.5% above the Medical Distribution industry median of 2.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Pharmagen (PHRX), the current OCF Margin % is 3.64% as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pharmagen Business Description

Industry Healthcare Medical Distribution

Comparable Companies FZMD SNYR SGMFF PMC EBOSF OMI UDHCF PBH PDCO SHPMY SHTDY HSIC ABC CAH MCK

Address 9337 Fraser Avenue, Silver Spring, MD, USA, 20910

Website http://pharmageninc.com

Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.